The Development of Oncolytic Adenovirus Therapy in the Past and Future - For the Case of Pancreatic Cancer
Journal:
Current Cancer Drug Targets
Volume:
18
Page:
153-161
Author(s):
Mizuho Sato-Dahlman and Masato Yamamoto*
Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune System
Journal:
Current Cancer Drug Targets
Volume:
18
Page:
124-138
Author(s):
Vincenzo Cerullo*, Cristian Capasso, Markus Vaha-Koskela, Otto Hemminki and Akseli Hemminki*
Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects
Journal:
Current Cancer Drug Targets
Volume:
18
Page:
177-187
Author(s):
Pavlos Msaouel, Mateusz Opyrchal, Angela Dispenzieri, Kah Whye Peng, Mark J. Federspiel, Stephen J. Russell and Evanthia Galanis*
Oncolytic Viruses: The Best is Yet to Come
Journal:
Current Cancer Drug Targets
Volume:
18
Page:
109-123
Author(s):
Chantal G. Lemay, Brian A. Keller, Robert E. Edge, Masato Abei and John C. Bell*
Epigenetics of Virus-Induced Tumors: Perspectives for Therapeutic Targeting
Journal:
Current Pharmaceutical Design
Volume:
23
Page:
4842-4861
Author(s):
Svetlana Vinokurova*
Multimodal HDAC Inhibitors with Improved Anticancer Activity
Journal:
Current Cancer Drug Targets
Volume:
18
Page:
39-56
Author(s):
Rainer Schobert and Bernhard Biersack*
Is there a Role for Epigenetic Enhancement of Immunomodulatory Approaches to Cancer Treatment?
Journal:
Current Cancer Drug Targets
Volume:
18
Page:
5-15
Author(s):
Kirsty J. Flower, Sadaf Ghaem-Maghami and Robert Brown*
Epigenetic Modulation Using Small Molecules - Targeting Histone Acetyltransferases in Disease
Journal:
Current Medicinal Chemistry
Volume:
24
Page:
4121-4150
Author(s):
Andre Richters and Angela N. Koehler*
The Emerging Role of the Hippo Pathway in Lung Cancers: Clinical Implications
Journal:
Current Drug Targets
Volume:
18
Page:
1880-1892
Author(s):
Seong Lin Teoh and Srijit Das*
Chemical Space of FLT3 Inhibitors as Potential Anti-AML Drugs
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
12
Page:
296-322
Author(s):
Qing-Yuan Lan, Yan-Le Zhi, Hao Heng, Jie-Yi Tian, Xiao-Xing Guo, Hai-Chun Liu, Ya-Dong Chen, Tao Lu* and Shuai Lu*